Form 4: Disc Medicine Officer William Jacob Savage Reports Sale of Common Stock
SEC Form 4 Filing
William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., reports selling 6,677 shares of common stock at a weighted average price of $50.0417.
Summary
- On May 20, 2025, William Jacob Savage, the Chief Medical Officer of Disc Medicine, Inc. (IRON), sold 6,677 shares of common stock.
- The sale was executed at a weighted average price of $50.0417 per share, with individual transactions ranging from $50.00 to $50.16.
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2024.
- Following the reported transaction, Savage directly owns 59,721 shares of Disc Medicine, Inc.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by an officer. The Rule 10b5-1 plan suggests the sale was pre-planned and not based on current market sentiment.
Industry Context
This filing is a routine disclosure of insider trading activity. It is important to monitor such filings to understand management's perspective on the company's stock.
Stakeholder Impact
- The sale of shares by a company officer could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2024-11-18 | Date of adoption of Rule 10b5-1 trading plan |
| 2025-05-20 | Date of stock sale transaction |
| 2025-05-22 | Date of Form 4 filing |
Keywords
Form 4, Disc Medicine, IRON, William Jacob Savage, Chief Medical Officer, Stock Sale, Rule 10b5-1 Trading Plan, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.